Intended Purpose: The EU AI Act's Classification Anchor

Under Regulation (EU) 2024/1689, "intended purpose" is the use for which a provider has designed and documented an AI system — encompassing the specific context and conditions of use, as stated in the instructions for use, in promotional or sales materials, and in the technical documentation. It is defined in Article 3, point 12. The concept matters because classification, conformity obligations, and role allocation all turn on what a system is documented to do, not merely what it is technically capable of doing.

The EU AI Act definition

Article 3, point 12 of Regulation (EU) 2024/1689 defines intended purpose as "the use for which an AI system is intended by the provider, including the specific context and conditions of use, as specified in the information supplied by the provider in the instructions for use, promotional or sales materials and statements and technical documentation."

Three documentation sources are named in that definition, and all three carry weight:

Instructions for use are the operational guide a provider gives to deployers and users — the who, what, and under what conditions. Promotional or sales materials and statements capture what the provider has communicated to the market about the system's function, even informally in pitch decks or website copy. Technical documentation (governed by Article 11 and detailed in Annex IV) sets out the system's design rationale, training approach, capabilities, and limitations.

The reach of that third source is significant. A provider cannot claim a narrow intended purpose in the instructions while marketing the system for a broader application. All three sources are read together; inconsistencies work against the provider. Regulators and market-surveillance authorities can draw on any of them.

This is why the documentation a provider produces is not merely a compliance formality — it defines the legal perimeter of the system's obligations. What a provider writes determines what tier applies.

Intended purpose vs reasonably foreseeable misuse

The Act pairs intended purpose with a closely related concept: "reasonably foreseeable misuse," defined in Article 3, point 13 as use "in a way that is not in accordance with its intended purpose, but which may result from reasonably foreseeable human behaviour or interaction with other systems."

The distinction matters because the obligations do not stop at the intended use. Article 9, which requires providers of high-risk AI systems to establish a risk management system, explicitly covers both. Providers must identify and analyse the risks associated with the system's intended purpose and also consider how the system could be misused in foreseeable ways — including by deployers who push the system beyond its stated scope, or by end users who adapt it in ways the provider did not anticipate.

In practice this means a provider cannot document a narrow intended purpose and then ignore the obvious ways that a deployer might stretch it. If a recruitment tool is documented for filtering incoming applications but could plausibly be repurposed to evaluate existing employees for promotion or termination, that foreseeable extension of use needs to be addressed in the risk management system. Mitigations might include contractual restrictions in the terms of service, technical guardrails, or explicit warnings in the instructions for use.

The Article 9 risk management system is a living process, not a one-time assessment. It must be updated throughout the system's lifecycle, and the intended purpose, along with foreseeable misuse scenarios, sits at its centre.

Why it matters for classification and roles

The most consequential use of intended purpose in the Act is classification. Article 6 determines whether an AI system is high-risk by testing whether it falls within Annex III — the list of eight high-risk use-case areas — in conjunction with the Article 6(3) filter, which can exclude a system from the high-risk tier if it does not pose a significant risk of harm despite falling within an Annex III area.

That classification test is applied to the system's intended purpose. A general-purpose scheduling tool is classified by what it is documented to do — schedule tasks. A model with identical underlying architecture, documented and marketed as a tool to rank employee performance or allocate tasks based on productivity monitoring, falls squarely within Annex III point 4 (employment and workers management). Same technology, different intended purpose, different risk tier, entirely different compliance stack.

This means providers cannot escape classification by understating the system's purpose. If promotional materials describe performance ranking and the instructions for use describe scheduling, the full set of documentation is examined. Writing a conservative intended purpose that does not reflect the system's actual marketed use is both legally fragile and — if the system does cause harm — potentially material to liability.

Changing the intended purpose triggers substantial modification. Article 3, point 23 defines substantial modification as a change to a high-risk AI system that affects compliance with the Act's requirements or that alters the intended purpose for which the system was assessed. If a provider narrows, broadens, or redirects an AI system's documented purpose after the initial conformity assessment, that may constitute a substantial modification, requiring a fresh assessment under Article 43 before the modified system is placed back on the market. The original CE marking and declaration of conformity relate to the original intended purpose; they do not travel automatically to a new one.

Deployers face their own exposure. Article 25 provides that where a deployer modifies the intended purpose of a high-risk AI system — or uses a general-purpose system for a high-risk purpose — the deployer becomes the provider of the modified or repurposed system and inherits the full provider obligations under Article 16. This is the role-shift mechanism: a deployer who takes a system outside its documented scope does not simply breach a deployer obligation; they become a provider. That shift carries the entire Article 16 stack — technical documentation, quality management under Article 17, conformity assessment under Article 43, registration under Article 49, CE marking under Article 48, and appointment of an authorised representative if based outside the EU.

Even short of a formal role-shift, a deployer using an AI system outside its intended purpose — without formally modifying it — is still in breach of Article 26, which requires deployers to use the system in accordance with its intended purpose and the provider's instructions.

Examples

Consider a software company that develops a machine-learning model capable of analysing written text and inferring structured attributes from it. If the company documents and markets the system as a tool for sorting incoming customer service tickets by topic, the intended purpose is categorisation of unstructured text in a customer service context — a minimal-risk function. No Annex III area is engaged; no high-risk obligations arise.

Now the same company launches a second product line using the same model. It is marketed to HR departments as a recruitment screening tool that ranks job applicants by predicted suitability. The instructions for use describe how the system scores CVs and cover letters, and the sales materials include case studies from talent acquisition teams. The intended purpose is now the assessment of persons in the context of recruitment — Annex III point 4(a). The model does not change; the documented purpose does. The second product requires a full high-risk compliance programme: an Article 9 risk management system, Article 10 data governance, Article 11 / Annex IV technical documentation, Article 14 human oversight provisions, a conformity assessment under Article 43 (Annex VI internal control applies to Annex III point 4), registration in the EU database under Article 49, and an EU Declaration of Conformity under Article 47. The first product requires none of those.

A cleaner deployment scenario illustrates the deployer angle. A logistics company buys a workforce scheduling tool whose intended purpose — documented by the provider — is shift planning based on operational demand. The company's operations team, without involving the provider, begins using it to score individual worker performance and flag employees for performance management reviews. That use is outside the documented intended purpose. The logistics company has now, in the language of Article 25, modified the intended purpose of the system. Depending on the significance of the change, it may have become the provider of a high-risk AI system covering worker management (Annex III point 4) — with the associated obligations falling on it, not the original vendor. At minimum, it is in breach of Article 26.

Frequently Asked Questions

Does the intended purpose have to match across all documentation sources, or can different sources describe different uses?

All documentation sources are read together under Article 3, point 12. A narrow intended purpose in the instructions for use does not override broader claims in marketing materials or technical documentation. Inconsistency between sources creates legal exposure: regulators can rely on any of the three, and a system will typically be classified by its broadest documented use. Providers should audit all three sources for alignment before placing a system on the market.

If we add a new feature to a deployed AI system, does the intended purpose automatically change?

Not automatically — it depends on what the feature does. If the new feature falls within the scope of the original intended purpose as documented, and does not alter the system's risk profile in ways that affect compliance, the change is more likely to be considered routine maintenance or a minor update. If the feature extends the system's use into a new context, a new user group, or a new type of decision-making — particularly one that falls within an Annex III area — that may constitute a change in intended purpose and trigger the substantial-modification assessment under Article 3, point 23.

Can a deployer specify their own intended purpose independently of the provider's documentation?

A deployer can use a system only within the intended purpose defined by the provider. If a deployer needs the system to serve a different purpose, they must either negotiate with the provider to extend the documented scope — which may trigger the provider's own conformity obligations — or accept that they are stepping into provider status under Article 25. What a deployer cannot do is document their own, wider intended purpose for a system and then rely on the provider's conformity assessment and CE marking to cover that use.

Does intended purpose affect the risk management system?

Directly. The Article 9 risk management system is built around the intended purpose and the reasonably foreseeable misuse scenarios derived from it. The risk identification and analysis, the mitigation measures, and the residual risk evaluation all start from the documented intended purpose. A precise, realistic intended purpose makes the Article 9 analysis tractable; a vague or over-broad intended purpose makes it impossible to scope, and creates liability if the system causes harm that a narrower purpose would have excluded.

What happens if the intended purpose is changed after CE marking and market placement?

If the change constitutes a substantial modification — as defined in Article 3, point 23 — the provider must re-run the conformity assessment under Article 43, issue a new or updated EU Declaration of Conformity under Article 47, update the technical documentation, and re-register the system if required. The CE marking issued for the original intended purpose does not extend to the changed system. For providers already on the market this is a non-trivial exercise — technical documentation under Annex IV is extensive, and the conformity assessment for Annex III point 4 (employment) requires the internal control procedure of Annex VI in full.

How does intended purpose interact with the Article 6(3) exemption?

Article 6(3) allows a provider to argue that a system falling within an Annex III area is not high-risk because it does not pose a significant risk of harm — for example, because it performs a narrow procedural task, improves the result of a previously completed human activity, or does preparatory work without replacing human assessment. That argument must be grounded in the actual intended purpose as documented. A provider cannot claim an Article 6(3) exemption based on a restricted intended purpose while marketing the system for a use that would clearly expose natural persons to significant risk. The exemption assessment must be documented and the system must still be registered under Article 49, even if the provider concludes it is not high-risk.

Related terms

• Substantial modification — Article 3, point 23
• Article 6: High-risk AI classification
• AI risk classification under the EU AI Act
• Annex IV: Technical documentation requirements
• Provider vs deployer: roles under the EU AI Act
• Safety component: Annex I and the product-safety route